Arrowhead Pharmaceuticals, Inc. (0HI3.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.53B |
| Enterprise Value | 5.04B |
| P/E Ratio | -38.32 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 18.57 |
| Price/Book Ratio | 19.02 |
| Enterprise/Revenue | 20.47 |
| Enterprise/EBITDA | -94.71 |
Fiscal Year
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.48 |
| Operating Margin | -0.36 |
AD
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -0.55 |
Income Statement
| Revenue | 829.45M |
| Revenue/Share | 4.37 |
| Gross Profit | 805.52M |
| EBITDA | 164.82M |
| Net Income | -1.63M |
| Diluted EPS | -0.01 |
Balance Sheet
| Total Cash | 1.78B |
| Total Cash/Share | 12.53 |
| Total Debt | 1.37B |
| Total Debt/Equity | 2.24 |
| Current Ratio | 6.23 |
| Book Value Per Share | 4.21 |
Price History
| 52-Week Change | 437.72 |
| 52-Week High | 84 |
| 52-Week Low | 20.75 |
| Moving Average 50 Days | 32.83 |
| Moving Average 200 Days | 31.06 |
Statistics
| Average Volume | 1,779 |
| Shares Outstanding | 139.12M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
